Sara C. Croca
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Controlling cardiovascular risk factors reduces progression of atherosclerosis in a multiethnic cohort of patients with lupus.
Journal: Lupus science & medicine
Published: February 03, 2026
Extent of vascular plaque predicts future cardiovascular events in patients with systemic lupus erythematosus.
Journal: Rheumatology (Oxford, England)
Published: December 13, 2021
Serum Metabolomic Signatures Can Predict Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: February 04, 2021
Total plaque area and plaque echogenicity are novel measures of subclinical atherosclerosis in patients with systemic lupus erythematosus.
Journal: Rheumatology (Oxford, England)
Published: July 02, 2020
Atherosclerosis in systemic lupus erythematosus.
Journal: Best practice & research. Clinical rheumatology
Published: July 05, 2017
Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study.
Journal: Arthritis research & therapy
Published: January 06, 2017
Cross-talk between iNKT cells and monocytes triggers an atheroprotective immune response in SLE patients with asymptomatic plaque.
Journal: Science immunology
Published: June 23, 2016
IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study.
Journal: Arthritis research & therapy
Published: July 09, 2014
Serum nitrated nucleosome levels in patients with systemic lupus erythematosus: a retrospective longitudinal cohort study.
Journal: Arthritis research & therapy
Published: August 30, 2013
Long-term activity index after renal failure in a cohort of 32 patients with lupus nephritis.
Journal: Clinical and experimental rheumatology
Published: March 27, 2013
Serum rituximab levels and efficiency of B cell depletion: differences between patients with rheumatoid arthritis and systemic lupus erythematosus.
Journal: Rheumatology (Oxford, England)
Published: February 21, 2013
Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts.
Journal: Autoimmunity reviews
Published: October 01, 2011
Last Updated: 09/26/2026